Funder: Patient-Centered Outcomes Research Institute
Due Dates (Anticipated): May 2026 (Letter of Intent) | September 2026 (Full Application)
Funding Amounts: Category 1: ≤$5M direct costs; Category 2: $5M–$12M direct costs; Category 3 (PCORnet®): ≤$12M direct costs; up to 5 years; total program up to ~$120M
Summary: Supports high-quality comparative clinical effectiveness research aligned with national health priorities, with special emphasis on maternal sleep health and mental health in Alzheimer's disease and related dementias.
Key Information: Individuals may not apply; foreign applicants must justify U.S. healthcare relevance and engagement.